Australian optometrists and ophthalmologists can use amniotic membrane grafts as regenerative therapy for a variety of ocular surface disease diagnoses including dry eye under a special access TGA scheme.
iCare is providing members of Optometry Australia, who co-manage glaucoma, with the opportunity to take part in a pilot program for the next generation iCare HOME, a device designed to improve the management of glaucoma.
Nearly one in three Indigenous Australians now access eye health services, with one in seven having eye examinations by an optometrist or ophthalmologist, a new report reveals.
Only 10 per cent of Australians in their 50s can identify major AMD risk factors but optometrists can expect more in this age group to have macula checks after the launch of a new Check My Macula campaign.
Melbourne optometrist Jim Papas is offering Optometry Australia members a free three-month trial of the unique myeyes® software platform that he developed.
Victorian Premier announced that optometrists can resume routine face-to-face care from 11.59pm tonight, Sunday 18 October. Read more.
“Make this your year of good vision for life”. Optometry Australia’s National Marketing Manager Trinity Scarf explains how Optometry Australia has pivoted its consumer awareness campaign.
A new scoring system to make it easier for optometrists to manage choroidal naevi and detect ocular melanomas has been developed but its creators need Australian optometrists’ help to validate the system.
Widespread use of face masks during the coronavirus pandemic is leading to a new phenomenon – mask-associated dry eye or MADE.
Read in September’s Pharma how the TGA’s Black Triangle Scheme provides a pathway to report adverse events when using new medications including ophthalmic preparations.
